Research
BRT has been tested and approved throughout Europe
and Canada, and it is in use in 85 countries worldwide. In Germany,
where it was developed by Regumed,
BRT has been in use for over 25 years. The following scientific
studies have provided objective proof of its effectiveness, and
hundreds of thousands of patients have been helped for more than
two decades.
Allergic Diseases Study Title: The Clinical Results
of BICOM® 2000
Bio-Resonance Device for Treatments of Allergic Diseases
Summary: The results show that the total effectiveness
rate of this device in desensitization treatment reaches as high as 89%
and total recovery rate is 78%. This study was conducted by Yuan Ze,
Huang Jiali, Wang Haiyan and Yu Chunyan (Department of Pediatrics of
Xi’an Central Hospital, Xi’an)
 [download
PDF (212k)]
Asthma Study Title: Clinical Observations
of 300 Children Suffering
from Asthma Treated with BICOM® 2000 Bio-Resonance Device
Summary: From May to December of 2003, the Asthma Research
Center of Jinan Children’s Hospital introduced the German manufactured
BICOM® 2000 to treat 415 children suffering from asthma, 300 of whom
were treated with the desensitization method. The total effectiveness
rate reaches as high as 93.3%.
[download
PDF (212k)]
Allergic Skin Diseases Study Title: Clinical Observation
of 79 Cases of Allergic Skin Diseases Treated with BICOM® 2000
Bio-Resonance Device
Summary: This article reports the clinical
observation of 79 cases of allergic skin diseases treated
with BICOM® 2000 bio-resonance device. After tests
and desensitization treatments were administered, the
total effectiveness rate is 89.9% and recovery rate is
74.7%. Study was conducted by Yang Jinzhi, The Department
of Allergy of Jinan Children’s Hospital
[download
PDF (212k)]
Amphibian Study Title: Transfer of molecular
information using a bioresonance instrument (BICOM®) in amphibian
trials (controlled blind study)
Summary: Two independent double-blind
studies, performed in Austria and Italy, demonstrated
that bioinformation can be scanned and transferred by
a bioresonance instrument (BICOM®). The metamorphosis
of tadpoles could be greatly slowed down by transferring
information from a toxic solution of the hormone thyroxin
to the aquarium water in a number of parallel trials.
[download
PDF (212k)]
Bowel Study Title: Noteworthy Therapy
Results in Chronic Inflammatory Bowel Diseases with the Aid of
BICOM® Bioresonance – Are ulcerative colitis and Morbus
Crohn (Ileitis terminalis) really incurable diseases?
Summary: The etiopathogenesis of chronic
inflammatory bowel diseases, which are increasing in
frequency similar to diseases with displaced symptoms,
is, according to medical science, unclear to this day.
But their latest investigations allow the supposition
of a multifactorial genetic disposition. A causal relation
between dietary factors and the possibility of curing
these bowel diseases is so far being considered as
scientifically unproved. Morbus Crohn and ulcerative
colitis are currently classified as chronic, incurable
diseases, which patients have to contend with for their
entire lives.
[download
PDF (148k)]
Liver Study Title: Prospective randomised
study to check the results of treatment using endogenous electromagnetic
fields, in the case of slight liver cell damage
Summary: The aim of the present trial
was to check, using a defined clinical picture, whether
measurable changes in biochemical parameters could be
induced by bioresonance treatment. A group of patients
with chronic liver disease was selected for this purpose
and the target criterion was a reduction in the activity
of enzymatic indicators of liver damage (GOT, GPT, gamma-GT)
in the blood of treated patients as compared with a non-treated
control group.
[download
PDF (328k)]
[BACK TO TOP]
|
